Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
OtherPractice

Effectiveness of the trivalent influenza vaccine

Michael R. Kolber, Darren Lau, Dean Eurich and Christina Korownyk
Canadian Family Physician January 2014; 60 (1) 50;
Michael R. Kolber
Associate Professor in the Department of Family Medicine at the University of Alberta in Edmonton.
MD CCFP MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darren Lau
Medical-doctoral student in the Faculty of Medicine and Dentistry at the University of Alberta.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dean Eurich
Associate Professor in the Li Ka Shing Centre for Health Research Innovation at the University of Alberta.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Korownyk
Assistant Professor in the Department of Family Medicine at the University of Alberta.
MD CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Clinical question

Does the seasonal trivalent influenza vaccine (flu shot) prevent influenza or its complications in adults and seniors?

Bottom line

For healthy adults, the flu shot reduces the influenza rate when the vaccine is well matched (number needed to treat [NNT] of 12 to 37). A poorly matched vaccine has diminished effectiveness. For community-dwelling seniors, the NNT to prevent 1 case of influenza is 40. The flu shot has not been shown to decrease hospitalizations. Evidence that the flu shot decreases mortality is likely biased.

Evidence

For those aged 16 to 65 years:

  • Meta-analysis of 17 flu-shot RCTs in 38 800 adults.1

    • -Influenza with well-matched vaccine (matches ≥ 80% of circulating virus) = 1.2% and with control = 3.9%; NNT = 37.

    • -Influenza with poor or uncertain vaccine match = 1.1% and with control = 2.4%; NNT = 77.

    • -Number of sick days decreased (by about half a day) when vaccine was matched.

    • -Hospitalization (2 trials) and pneumonia rates (1 trial) were not affected and mortality rates were not reported.

    • -Limitations: most studies examined 1 influenza season, many included health care workers or children, and some examined epidemics from 30 years ago.

  • Systematic review of 8 RCTs reported NNT = 67 for flu shot.2

  • The most generalizable RCT involved American factory workers during 2 influenza seasons.3

    • -Influenza with well-matched vaccine = 1.4% and with placebo = 10.2%; NNT = 12.

    • -No statistical difference for poor vaccine match.

For seniors aged 65 years or older:

  • Authors of a meta-analysis concluded they were unable to determine the flu shot’s effectiveness in seniors.4

  • The highest-quality flu-shot RCT in 1838 community-dwelling seniors found influenza with vaccine = 1.7% and with placebo = 4.2%; NNT = 40.5

Context

  • The flu shot is updated annually to match predicted strains and, in Canada, was well matched in 7 of the past 14 years (calculated with data from www.phacaspc.gc.ca/fluwatch).

  • Localized (pain) and systemic (fever or myalgia) adverse events are more common with the flu shot than with placebo.1,4

  • Observational evidence that the flu shot reduces hospitalizations and mortality6 is biased by healthier patients more often choosing vaccination.4,7

  • Canadian guidelines recommend universal flu shots.8

Implementation

Influenza is prevented primarily through hand washing and vaccination.9 In the past, only about 30% of Canadians and 40% of health care workers received flu shots.10,11 Influenza treatment is primarily supportive. The apparent effectiveness of neuraminidase inhibitors such as oseltamivir in treating influenza (symptom resolution about 1 day earlier; 6.7 vs 5.8 days) is likely biased; most oseltamivir trials are not published and there is selective reporting of adverse events.12,13 To increase vaccination, public campaigns and personal reminders might be beneficial.12 Patient education addressing myths (eg, the flu shot causes influenza; the vaccine is unsafe) is essential.

Notes

Tools for Practice articles in Canadian Family Physician (CFP) are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in CFP are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

  • The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Jefferson T,
    2. Di Pietrantonj C,
    3. Rivetti A,
    4. Bawazeer GA,
    5. Al-Ansary LA,
    6. Ferroni E
    . Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010;(7):CD001269.
  2. 2.↵
    1. Osterholm MT,
    2. Kelley NS,
    3. Sommer A,
    4. Belongia EA
    . Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12(1):36-44.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bridges CB,
    2. Thompson WW,
    3. Meltzer MI,
    4. Reeve GR,
    5. Talamonti WJ,
    6. Cox NJ,
    7. et al
    . Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000;284(13):1655-63.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Jefferson T,
    2. Di Pietrantonj C,
    3. Al-Ansary LA,
    4. Ferroni E,
    5. Thorning S,
    6. Thomas RE
    . Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010;(2):CD004876.
  5. 5.↵
    1. Govaert TME,
    2. Thijs CTMCN,
    3. Masurel N,
    4. Sprenger MJW,
    5. Dinant GJ,
    6. Knottnerus JA
    . The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272(21):1661-5.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Nichol KL,
    2. Nordin JD,
    3. Nelson DB,
    4. Mullooly JP,
    5. Hak E
    . Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007;357(14):1373-81.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Eurich DT,
    2. Marrie TJ,
    3. Johnstone J,
    4. Majumdar SR
    . Mortality reduction with influenza vaccine in patients with pneumonia outside “flu” season: pleiotropic benefits or residual confounding? American J Resp Crit Care Med 2008;178(5):527-33.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. National Advisory Committee on Immunization
    . Statement on seasonal influenza vaccine for 2013–2014. Can Commun Dis Rep Wkly 2013;39(ACS-4):1-37.
    OpenUrl
  9. 9.↵
    1. Morabia A,
    2. Costanza MC
    . Handwashing against hospitalization for influenza: time for PHIR? Prev Med 2012;54(6):369-70.
    OpenUrlPubMed
  10. 10.↵
    1. Johansen H,
    2. Sambell C,
    3. Zhao W
    . Flu shots—national and provincial/territorial trends. Health Rep 2006;17(2):43-8.
    OpenUrlPubMed
  11. 11.↵
    1. Lam PP,
    2. Chambers LW,
    3. Pierrynowski MacDougall DM,
    4. McCarthy AE
    . Seasonal influenza vaccination campaigns for health care personnel: systematic review. CMAJ 2010;182(12):E542-8.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Lau D,
    2. Hu J,
    3. Majumdar SR,
    4. Storie DA,
    5. Rees SE,
    6. Johnson JA
    . Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis. Ann Fam Med 2012;10(6):538-46.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Jefferson T,
    2. Jones MA,
    3. Doshi P,
    4. Del Mar CB,
    5. Heneghan CJ,
    6. Hama R,
    7. et al
    . Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2012;(1):CD008965.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 60 (1)
Canadian Family Physician
Vol. 60, Issue 1
1 Jan 2014
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of the trivalent influenza vaccine
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effectiveness of the trivalent influenza vaccine
Michael R. Kolber, Darren Lau, Dean Eurich, Christina Korownyk
Canadian Family Physician Jan 2014, 60 (1) 50;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Effectiveness of the trivalent influenza vaccine
Michael R. Kolber, Darren Lau, Dean Eurich, Christina Korownyk
Canadian Family Physician Jan 2014, 60 (1) 50;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical question
    • Bottom line
    • Evidence
    • Context
    • Implementation
    • Notes
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • How missing evidence-based medicine indicators can inform COVID-19 vaccine distribution policies: a scoping review and calculation of indicators from data in randomised controlled trials
  • COVID-19 vaccines and evidence-based medicine
  • Google Scholar

More in this TOC Section

Practice

  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
Show more Practice

Tools for Practice

  • Testosterone supplementation for men
  • Time to challenge penicillin allergy labels
  • Antibiotics for acute diverticulitis
Show more Tools for Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire